J. Warwicker

The Use of Antibodies in Small-Molecule Drug Discovery

M. Hebditch, C. Marsden, Sonia Eckersley, 2014, Journal of biomolecular screening.

A-loop interactions in Mer tyrosine kinase give rise to inhibitors with two-step mechanism and long residence time of binding

J. Nissink, R. Overman, P. Rawlins, 2020, The Biochemical journal.

Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours

C. Harbron, D. Hodgson, A. Lau, 2013, Virchows Archiv.

Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B

A. Barr, K. Fütterer, S. Pollack, 2019, bioRxiv.

Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy.

Anthony D. Keefe, E. Hennessy, A. Keefe, 2021, Journal of medicinal chemistry.

Calculation of Cys 30 ΔpKa's and oxidising power for DsbA mutants

J. Warwicker, P. Gane, Jim Warwicker, 1996 .

Tool inhibitors and assays to interrogate the biology of the TRAF2 and NCK interacting kinase.

S. Haggarty, R. Bürli, N. Brandon, 2019, Bioorganic & medicinal chemistry letters.